Abstract:Highlight • The effective integration of machine learning and genetic algorithms to optimize peptide modifications offers a promising avenue for peptide design. • It introduces novel techniques for the directly modification of small peptides, particularly in cases where insufficient data is available for traditional approaches. • It strategically positions the introduction of positive charge amino acids via our model instead of a mere cumulative addition of positive charged amino-acids. • Minimal modifications to the peptide structure can exert a profound influence on the inhibitory activity of LPS-binding peptides. Introduction Antimicrobial peptides (AMPs) are valuable alternatives to traditional antibiotics, possess a variety of potent biological activities and exhibit immunomodulatory effects that alleviate difficult-to-treat infections. Clarifying the structure-activity relationships of AMPs can direct the synthesis of desirable peptide therapeutics. Objectives In this study, the lipopolysaccharide-binding domain (LBD) was identified through machine learning-guided directed evolution, which acts as a functional domain of the anti-lipopolysaccharide factor family of AMPs identified from Marsupenaeus japonicus . Methods LBD A-D was identified as an output of this algorithm, in which the original LBD Mj sequence was the input, and the three-dimensional solution structure of LBD B was determined using nuclear magnetic resonance. Furthermore, our study involved a comprehensive series of experiments, including morphological studies and in vitro and in vivo antibacterial tests. Results The NMR solution structure showed that LBD B possesses a circular extended structure with a disulfide crosslink at the terminus and two 3 10 -helices and exhibits a broad antimicrobial spectrum. In addition, scanning electron microscopy (SEM) and transmission electron microscopy (TEM) showed that LBD B induced the formation of a cluster of bacteria wrapped in a flexible coating that ruptured and consequently killed the bacteria. Finally, coinjection of LBD B , Vibrio alginolyticus and Staphylococcus aureus in vivo improved the survival of M. japonicus , demonstrating the promising therapeutic role of LBD B for treating infectious disease. Conclusions The findings of this study pave the way for the rational drug design of activity-enhanced peptide antibiotics. Graphical abstract Download : Download high-res image (110KB) Download : Download full-size image Employing machine learning and genetic algorithms, we developed structurally enhanced antimicrobial peptides boasting exceptional efficacy.

C-terminal modification of a<i> de</i><i> novo</i> designed antimicrobial peptide via capping of macrolactam rings

Antimicrobial activity and properties of de novo design of short synthetic lipopeptides

New peptide deformylase inhibitors design, synthesis and pharmacokinetic assessment

Optimization of Antibacterial Cyclic Decapeptides.

Design and Synthesis of New N-terminal Fatty Acid Modified-Antimicrobial Peptide Analogues with Potent in Vitro Biological Activity.

Relationship Between Peptide Structure and Antimicrobial Activity As Studied by De Novo Designed Peptides.

The Antimicrobial Peptide Capitellacin: Chemical Synthesis of Analogues to Probe the Role of Disulphide Bridges and Their Replacement with Vinyl Sulphides

Semisynthetic Macrocyclic Lipo-lanthipeptides Display Antimicrobial Activity Against Bacterial Pathogens

De novo Design of Tryptophan containing Broad‐Spectrum Cationic Antimicrobial Octapeptides

De Novo Design of a Leu-Arg-rich Antimicrobial Peptide

Rational Design of Cationic Antimicrobial Peptides by the Tandem of Leucine-Rich Repeat.

Machine learning and genetic algorithm-guided directed evolution for the development of antimicrobial peptides

Switching from Membrane Disrupting to Membrane Crossing, an Effective Strategy in Designing Antibacterial Polypeptide

Design and Synthesis of Biocompatible, Hemocompatible, and Highly Selective Antimicrobial Cationic Peptidopolysaccharides Via Click Chemistry

Biosynthesis of 2-aminooctanoic acid and its use to terminally modify a lactoferricin B peptide derivative for improved antimicrobial activity

De Novo Design of Na+-activated Lipopeptides with Selective Antifungal Activity: A Promising Strategy for Antifungal Drug Discovery.

Novel Design of Short Antimicrobial Peptides Derived from the Bactericidal Domain of Avian Β-Defensin-4.

Covalent conjugation of cationic antimicrobial peptides with a β‐lactam antibiotic core

Segment-Based Peptide Design Reveals the Importance of N-Terminal High Cationicity for Antimicrobial Activity Against Gram-Negative Pathogens

Designing double-site lipidated peptide amphiphiles as potent antimicrobial biomaterials to combat multidrug-resistant bacteria

de Novo-designed antimicrobial peptides with broad-spectrum antimicrobial potency and rapid wound disinfection